Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3695751016 | Product containing heparinoid and salicylic acid in transdermal dosage form | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3695752011 | Product containing heparinoid and salicylic acid in transdermal dosage form (medicinal product form) | en | Fully specified name | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3695753018 | Heparinoid and salicylic acid in transdermal dosage form | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3710262013 | Heparinoid- and salicylic acid-containing product in transdermal dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3710263015 | Product containing heparinoid and salicylic acid in transdermal dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Heparinoid- and salicylic acid-containing product in transdermal dose form | Is a | Product containing heparinoid (medicinal product) | false | Inferred relationship | Some | ||
| Heparinoid- and salicylic acid-containing product in transdermal dose form | Has manufactured dose form | Transdermal dose form (dose form) | true | Inferred relationship | Some | ||
| Heparinoid- and salicylic acid-containing product in transdermal dose form | Is a | Product manufactured as transdermal dose form (product) | true | Inferred relationship | Some | ||
| Heparinoid- and salicylic acid-containing product in transdermal dose form | Has active ingredient | Salicylic acid (substance) | true | Inferred relationship | Some | 2 | |
| Heparinoid- and salicylic acid-containing product in transdermal dose form | Is a | Product containing salicylic acid (medicinal product) | false | Inferred relationship | Some | ||
| Heparinoid- and salicylic acid-containing product in transdermal dose form | Has active ingredient | Heparinoid (substance) | true | Inferred relationship | Some | 1 | |
| Heparinoid- and salicylic acid-containing product in transdermal dose form | Is a | Heparinoid- and salicylic acid-containing product | true | Inferred relationship | Some | ||
| Heparinoid- and salicylic acid-containing product in transdermal dose form | Plays role | Antifungal therapeutic role (role) | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Heparinoid 2 mg/g and salicylic acid 20 mg/g transdermal cream | Is a | False | Heparinoid- and salicylic acid-containing product in transdermal dose form | Inferred relationship | Some | |
| Heparinoid and salicylic acid only product in transdermal dose form | Is a | True | Heparinoid- and salicylic acid-containing product in transdermal dose form | Inferred relationship | Some |
This concept is not in any reference sets
FHIR